These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 2884301

  • 1. Selectivity and specificity for alpha 1-adrenoceptor blocking activity of R(-)- and S(+)-YM-12617 orally administered to pithed, spontaneously hypertensive rats.
    Honda K, Momose N, Nakagawa C.
    J Pharm Pharmacol; 1987 Apr; 39(4):316-8. PubMed ID: 2884301
    [Abstract] [Full Text] [Related]

  • 2. Further studies on (+/-)-YM-12617, a potent and selective alpha 1-adrenoceptor antagonist and its individual optical enantiomers.
    Honda K, Nakagawa C, Terai M.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Sep; 336(3):295-302. PubMed ID: 2891044
    [Abstract] [Full Text] [Related]

  • 3. Effect of the optical isomers of YM-12617 on increased intra-urethral pressure induced by phenylephrine in anaesthetized dogs.
    Shibasaki M, Sudoh K, Inagaki O, Uchida W, Honda K.
    J Auton Pharmacol; 1992 Aug; 12(4):263-8. PubMed ID: 1355094
    [Abstract] [Full Text] [Related]

  • 4. Adrenoceptor blocking and cardiovascular effects of the optical isomers of amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent, and the corresponding desoxy derivative (YM-11133) in rats.
    Honda K, Nakagawa C, Inagaki O, Shibasaki M, Takenaka T, Takeda M.
    Jpn J Pharmacol; 1986 Aug; 41(4):459-66. PubMed ID: 2877109
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
    Inagaki O, Sudoh K, Shibasaki M, Nakagawa C, Honda K.
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):794-802. PubMed ID: 7532758
    [Abstract] [Full Text] [Related]

  • 6. Autonomic and antihypertensive activity of oral amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent in conscious rats.
    Honda K, Takenaka T, Shiono K, Miyata-Osawa A, Nakagawa C.
    Jpn J Pharmacol; 1985 May; 38(1):31-41. PubMed ID: 2862302
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent.
    Asano M, Uchida W, Shibasaki K, Terai M, Inagaki O, Takenaka T, Matsumoto Y, Fujikura T.
    J Pharmacol Exp Ther; 1990 Jul; 254(1):204-11. PubMed ID: 1973196
    [Abstract] [Full Text] [Related]

  • 8. Adrenoceptor blocking properties of the stereoisomers of amosulalol (YM-09538) and the corresponding desoxy derivative (YM-11133).
    Honda K, Takenaka T, Miyata-Osawa A, Terai M.
    J Pharmacol Exp Ther; 1986 Mar; 236(3):776-83. PubMed ID: 2869143
    [Abstract] [Full Text] [Related]

  • 9. Alpha-1 adrenoceptor antagonist effects of the optical isomers of YM-12617 in rabbit lower urinary tract and prostate.
    Honda K, Nakagawa C.
    J Pharmacol Exp Ther; 1986 Nov; 239(2):512-6. PubMed ID: 2877084
    [Abstract] [Full Text] [Related]

  • 10. Low concentrations of angiotensin II unmask vasoconstrictory alpha 2-adrenoceptors in isolated perfused kidneys of spontaneously hypertensive rats.
    Bohmann C, Rist W, Schollmeyer P, Rump LC.
    Cardiovasc Res; 1995 Dec; 30(6):857-65. PubMed ID: 8746199
    [Abstract] [Full Text] [Related]

  • 11. Sympathetic innervation and alpha-adrenoceptor profile of blood vessels in the posterior region of the rabbit knee joint.
    Najafipour H, Ferrell WR.
    Br J Pharmacol; 1993 Jan; 108(1):79-84. PubMed ID: 8094028
    [Abstract] [Full Text] [Related]

  • 12. In vivo pharmacological profile of SL 84.0418, a new selective, peripherally active alpha 2-adrenoceptor antagonist.
    Angel I, Grosset A, Perrault G, Schoemaker H, Langer SZ.
    Eur J Pharmacol; 1993 Apr 06; 234(2-3):137-45. PubMed ID: 8097719
    [Abstract] [Full Text] [Related]

  • 13. The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist.
    Brown CM, MacKinnon AC, Redfern WS, Hicks PE, Kilpatrick AT, Small C, Ramcharan M, Clague RU, Clark RD, MacFarlane CB.
    Br J Pharmacol; 1993 Feb 06; 108(2):516-25. PubMed ID: 8095420
    [Abstract] [Full Text] [Related]

  • 14. Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats.
    Hashimoto H, Tanaka M, Kanda A, Akashi A.
    Drugs; 1988 Feb 06; 36 Suppl 6():31-6. PubMed ID: 2908302
    [Abstract] [Full Text] [Related]

  • 15. The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers.
    Riva E, Mennini T, Latini R.
    Br J Pharmacol; 1991 Dec 06; 104(4):823-8. PubMed ID: 1687367
    [Abstract] [Full Text] [Related]

  • 16. Difference in the potency of alpha 2-adrenoceptor agonists and antagonists between the pithed rabbit and rat.
    Bulloch JM, Docherty JR, Flavahan NA, McGrath JC, McKean CE.
    Br J Pharmacol; 1987 Jul 06; 91(3):457-66. PubMed ID: 2886172
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    Kenny BA, Miller AM, Williamson IJ, O'Connell J, Chalmers DH, Naylor AM.
    Br J Pharmacol; 1996 Jun 06; 118(4):871-8. PubMed ID: 8799556
    [Abstract] [Full Text] [Related]

  • 18. The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.
    Nichols AJ, Sulpizio AC, Ashton DJ, Hieble JP, Ruffolo RR.
    Chirality; 1989 Jun 06; 1(4):265-70. PubMed ID: 2577144
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.